
03 Feb 2022 Fundraising
Leukaemia UK awarded Christmas Grant to support life-saving research
Leukaemia UK are delighted to have been awarded a special Christmas Grant from Kusuma Trust UK.
The grant of £10,000 will support the life-saving leukaemia research projects that Leukaemia UK funds across the UK. This includes Leukaemia UK’s prestigious John Goldman Fellowships which fund novel research projects by early career researchers into treatments for leukaemia and Project Grants funding experienced researchers advancing the fundamental understanding of the disease.
Fiona Hazell, Chief Executive of Leukaemia UK, said “We are thrilled to have been awarded this grant from Kusuma Trust UK, which will help to support Leukaemia UK’s life-saving research programmes into kinder and more effective treatments. Kusuma Trust’s support will help us to progress the research that matters most to the tens of thousands of families impacted by a leukaemia diagnosis.”
The Kusuma Trust UK is a family led philanthropic trust established in 2010. The Trust gives grants to organisations based on shared values and mutual interests in the UK, Gibraltar and India. Its current areas of interest are creating access to opportunities, improving health and well-being, and investing in our communities and environment.”
The Kusuma Trust said “We were very impressed to learn about Leukaemia UK’s research into leukaemia and other blood cancers and related disorders, and how they are pioneering the development of improved care and support to those affected. We hope that our funding will help to continue doing this important work.”
This generous grant will go towards funding kinder and more effective treatments for leukaemia, such as the research being carried out by Dr Samanta Mariani into the role of macrophages in cases of infant leukaemia or by Dr Daniel Coleman into developing kinder treatments by targeting mutated RAS genes.
Related posts
31 October 2023
Chris Dew joins Leukaemia UK as Director of Finances & Resources
Leukaemia UK is delighted to announce the appointment of Chris Dew as Director of Finance & Resources, following ten years as Chief Financial Officer at musical therapy charity Nordoff-Robbins. The…
1 August 2022
A research breakthrough targets cancer over healthy tissue, bringing possibility of a new treatment option for most deadly type of leukaemia
A new scientific paper published on 22nd June in Science Translational Medicine, announced a breakthrough by Leukaemia UK-funded scientist Dr William Grey that could lead to a vital new treatment option for…
4 September 2023
Less than 1% of Brits can identify all the most common symptoms of one of the deadliest types of cancer
New research launched today by Leukaemia Care and Leukaemia UK reveals that less than 1% (0.4%) of UK adults can accurately identify the four most common symptoms of leukaemia –…
8 July 2025
The first ever leukaemia-dedicated pathway to improve diagnosis, treatment and care
The Best Practice Timed Pathway We’re delighted to share that Leukaemia UK, in partnership with Lymphoma Action and Myeloma UK, is working with the NHS England Cancer programme team to…